Signals Inbox·August 21, 2026·Defense Tech

Is Castelion really worth $13B today?

Castelion’s $13 billion valuation is aggressive but defensible today, but only if Blackbeard moves from a fast development program into high-volume missile production almost as quickly as investors now expect.

Q1How did Castelion suddenly become a $13 billion company?

Castelion’s jump to $13 billion is unusually aggressive even for today’s defense-tech market: its valuation has risen about 4.6 times since its previous round less than a year ago.

The company announced a Series C this week combining $800 million of equity with a $250 million committed revolving credit facility. JPMorganChase’s Strategic Investment Group, Andreessen Horowitz and Carlyle co-led the equity financing, with T. Rowe Price joining existing investors including Lightspeed, Altimeter and General Catalyst.

The comparison with December 2025 is striking. Castelion had then raised $350 million at a reported $2.8 billion valuation. Going from $2.8 billion to $13 billion represents a 364% increase in roughly eight months.

Castelion was founded in late 2022, so it reached $13 billion in under four years. Saronic, founded at roughly the same time, reached $9.25 billion this year. Helsing needed about five years to reach $18 billion. Anduril, founded in 2017, reached $61 billion after nine years. Castelion sits at the very fast end of a defense-tech market that is already repricing companies unusually quickly.

Defense-tech valuation speed comparison

Q2How much revenue does Castelion actually make today?

We still do not know Castelion’s real revenue, and that missing number is one of the biggest problems with trying to justify a $13 billion valuation.

Castelion does not publish revenue, gross margin or operating income. Growjo and GetLatka both put annual revenue at roughly $51.5 million around 2025, but these are modeled estimates rather than figures disclosed by the company. GetLatka explicitly says it has never interviewed Castelion management and that its number is estimated from public information.

We should therefore treat $51.5 million as a rough reference point, not as audited revenue. At that level, $13 billion equals about 252 times annual sales. Even if the estimate were spectacularly stale and Castelion were already making four times as much, around $200 million, the valuation would still equal 65 times revenue.

That historical number may already be getting stale. Castelion says it has secured more than $500 million of U.S. military contracts over the past 18 months, and its business is moving from paid development work toward actual missile procurement. Revenue could therefore rise very quickly from a small base.

Still, we cannot give Castelion credit today for revenue that has not yet been reported or earned. On the financial information currently available, $13 billion is a very expensive valuation.

Q3Is Castelion more expensive than Anduril, Shield AI and Saronic?

Yes. Castelion currently looks much more expensive than other richly valued defense startups unless its real revenue has already moved far above the outside estimates.

Anduril is the cleanest comparison. It raised $5 billion at a $61 billion valuation after reporting $2.2 billion of 2025 revenue, roughly 28 times trailing sales. That is already a huge multiple for a defense company, but Anduril had also more than doubled revenue in one year.

Shield AI raised at $12.7 billion while projecting more than $540 million of revenue this year and more than 80% growth. Its valuation is therefore below 24 times that revenue forecast.

Helsing is perhaps the best example of how far private defense valuations can stretch. The Financial Times recently calculated that its $18 billion valuation represented roughly 32 times projected revenue and quoted investors openly questioning whether defense tech had entered bubble territory.

Saronic provides an interesting younger comparison. It raised at $9.25 billion, while Sacra estimates roughly $200 million of 2025 revenue. That would put Saronic around 46 times sales, itself extremely high. Yet Castelion would still trade at more than five times that multiple if the $51.5 million revenue estimate is anywhere close to reality.

Defense startup valuation multiples

Q4How crazy does $13 billion look next to public defense companies?

Castelion already carries a higher valuation than Kratos, a public defense company expected to generate roughly $1.8 billion of revenue this year.

Kratos is particularly useful because it is closer to the defense-tech story than Lockheed Martin or RTX. Its rocket systems, hypersonics, unmanned aircraft and internally funded product development all appeal to many of the same investors. Kratos recently reported 30.5% quarterly revenue growth, raised full-year guidance to $1.75 billion to $1.81 billion and had about $2.1 billion of backlog. Its market capitalization has recently been around $10 billion to $11 billion.

So investors are currently valuing Castelion above a public company with more than $1.7 billion of expected annual sales.

At the other extreme, Rocket Lab shows that public markets can tolerate enormous multiples when investors believe a hardware company has rare technology and a huge future market. Rocket Lab recently had a market value around $48 billion while quarterly revenue was $234 million, equivalent to roughly $936 million if we simply annualize the quarter. That is still around 50 times sales.

Traditional primes sit much lower. Lockheed Martin, Northrop Grumman and RTX generate tens of billions in annual revenue and generally trade at only a few times sales because their growth is much slower.

Castelion can reasonably command a major growth premium. The uncomfortable part is just how much growth the current valuation already assumes.

Q5Is Castelion growing fast enough to catch up with its valuation?

Operational growth genuinely stands out. Revenue is the missing half: we still do not have enough data to know whether it is keeping up.

Consider what has changed in less than two years. Castelion went from early test vehicles to more than 25 flight tests, secured Army and Navy integration work, moved Blackbeard onto a path toward the F/A-18 Super Hornet and started preparing for early operational capability in 2027.

The contract progression is also getting larger. Forbes reported that Castelion had accumulated more than $100 million of military contracts by late 2025. The company now says it has secured more than $500 million over an 18-month period. That does not mean $500 million has already appeared as revenue, but the order book has clearly moved into a different range.

The physical company is changing just as quickly. Castelion has already committed more than $250 million of private money to Project Ranger, its roughly 1,000-acre New Mexico manufacturing campus, and the new financing will put hundreds of millions more into expanding production there and elsewhere.

So calling the valuation absurd purely from a 2025 revenue estimate would be too easy. Castelion is moving through development milestones unusually quickly. Investors are assuming that its financials will soon follow the same curve.

Q6Does Castelion already have real production demand?

Yes. Castelion has now crossed the important line from being paid mainly to develop Blackbeard toward being paid to manufacture actual weapons.

The clearest evidence came when the Navy placed a $23.4 million firm-fixed-price order for 50 Blackbeard early-operational-capability prototypes plus 50 shipping and storage containers. The order is due to be completed in 2027 and will exercise the production capacity at Project Ranger.

The Pentagon then went much further. Once Blackbeard completes testing and validation, its framework with Castelion calls for a two-year procurement contract with a guaranteed minimum of 500 missiles annually, with options that can extend the arrangement.

The Navy’s own budget documents are even more useful because they show planned quantities rather than company ambitions. The FY2027 request contains $156 million for 353 MACE all-up rounds, with Castelion identified as the prime contractor in Pentagon documentation. The Navy’s five-year planning material shows quantities rising to 691, then 976, 1,115 and 1,375 rounds in the following years, for 4,510 across the planning period.

Congress still has to fund future years, and procurement plans can change. Even so, we are well beyond a situation where Castelion is trying to persuade investors that somebody might eventually want thousands of cheap hypersonic missiles. The U.S. Navy is currently budgeting around that idea.

Q7Is Blackbeard actually as cheap as Castelion says?

The available procurement data suggests Blackbeard really is landing in the hundreds of thousands of dollars per weapon, which is probably Castelion’s most important achievement so far.

The first fixed-price Navy order was $23.4 million for 50 weapons and 50 containers. A simple division gives $468,000 per missile-and-container package. That is not a clean missile unit price because the contract includes the containers and other contractual costs, but it puts us in the right order of magnitude.

The Navy’s first planned bulk procurement points to almost exactly the same range. Its budget asks for $156 million for 353 MACE all-up rounds plus associated production engineering, logistics and program management. Dividing the entire amount by 353 gives roughly $442,000 per round, again with support costs included.

Two completely different procurement data points have therefore landed around $440,000 to $470,000. That makes the low-cost claim considerably more credible than a startup simply promising a future $300,000 missile.

For context, many existing long-range precision weapons cost several million dollars each, while sophisticated hypersonic systems can cost far more. Blackbeard does not need to match the absolute performance of every higher-end system for the economics to become attractive. At a few hundred thousand dollars per shot, commanders can start thinking in hundreds or thousands of weapons rather than carefully rationing a small inventory.

Q8How much revenue would Castelion need for $13 billion to look normal?

Castelion probably needs somewhere around $500 million to $1 billion of annual revenue before $13 billion starts looking financially comfortable.

At 30 times revenue, an exceptionally generous growth multiple, Castelion needs about $433 million of sales. At 20 times, it needs $650 million. At 15 times, it needs roughly $867 million. A 10-times multiple requires $1.3 billion.

The Navy’s planned production ramp makes those numbers less fantastical than they initially look. Its MACE plan reaches 976 weapons in one year, then 1,115 and 1,375. Using roughly $442,000 as a crude first-lot program-value reference, 1,000 rounds correspond to around $442 million. Castelion is also developing a ground-launched Blackbeard, a longer-range strike weapon and defensive systems.

We should be careful about adding every Pentagon quantity together. The separate government framework discussing more than 12,000 Blackbeards over five years may overlap with Navy MACE procurement, so treating them as independent orders would exaggerate the opportunity.

The threshold is simple: Castelion needs to become a business producing missiles in the high hundreds or thousands every year, while adding other programs, for $13 billion to stop looking extreme.

Revenue required to support a $13B valuation

Q9Is the Pentagon really shifting toward cheap missiles at scale right now?

Yes, and this is currently the strongest external argument for Castelion’s valuation because the shift is showing up across programs that have nothing to do with Castelion.

The Navy has just awarded RTX a $22.9 billion multiyear Tomahawk contract designed to push annual production above 1,000 missiles. RTX said earlier this year that Tomahawk, AMRAAM and several Standard Missile lines are being pushed toward production rates two to four times higher than before.

A few weeks earlier, the Army increased the ceiling on Lockheed Martin’s seven-year PAC-3 missile framework to $58.62 billion. Lockheed says the plan supports tripling PAC-3 MSE production capacity by 2030.

Congress is pushing in the same direction with newer suppliers. The House defense appropriations bill proposes $836 million specifically for new-entrant low-cost munitions, including $325 million for Army low-cost hypersonic strike and $156 million for the Navy program that includes MACE.

Taken together, this is a broad procurement change: larger contracts, longer commitments, higher annual quantities and explicit funding for cheaper new entrants. Castelion happened to build its company around exactly that problem.

The timing is especially favorable these days because recent conflicts have made missile inventories a political issue rather than an obscure industrial-base concern. The Pentagon wants more shots available, faster. Castelion does not have to create that demand from scratch.

Q10Is Blackbeard technically proven enough yet?

Blackbeard has enough technical credibility for the Pentagon to spend serious money on it, but it still has major tests to clear before we should treat successful fielding as guaranteed.

Castelion says it went from a clean-sheet design to more than 25 flight tests in under two and a half years. That is unusually fast for missile development. In late 2025, Saronic even used one of its autonomous vessels as an at-sea telemetry and communications node during a Castelion test, and the two companies are now working toward a maritime Blackbeard launch demonstration.

The Navy’s $105 million F/A-18 program shows where the remaining work sits. Castelion still has to complete aircraft hardware and software integration, system-safety work, airworthiness certification, carrier-related testing and additional flight tests before the weapon reaches early operational capability.

Public information also gives us far less detail about Blackbeard’s final performance than its production economics. Exact operational range, survivability, seeker performance and many other characteristics remain undisclosed. Some of the vehicles shown publicly during development were test articles rather than the final weapon configuration.

So we are confident that Castelion has built and repeatedly flown serious hardware. We are much less confident about how Blackbeard will perform once tested as a complete operational weapon in realistic military conditions. That uncertainty deserves a meaningful discount in the valuation.

Q11Does Castelion have a real moat, or just a head start?

Castelion currently has a meaningful manufacturing head start, and the moat will become much stronger if high-volume production works as planned.

Its advantage starts with vertical integration. Castelion builds important parts of propulsion, guidance and other subsystems itself, while using suppliers from industries outside traditional aerospace where possible. The founders told Forbes that they deliberately went looking for automotive and industrial components to avoid aerospace prices and long lead times.

Frequent testing strengthens that model. More than 20 flights in one year gave Castelion many chances to discover manufacturing and engineering problems in actual hardware. The company can then change the design, factory process and suppliers together rather than waiting for a traditional multiyear development milestone.

Project Ranger adds another layer. A dedicated site capable of eventually producing thousands of weapons gives Castelion infrastructure built around Blackbeard’s economics from day one.

None of those advantages is impossible to copy. The difficult part for competitors is reproducing the whole loop: cheap design choices, vertical integration, fast testing, private capital invested before guaranteed orders and a factory optimized for large quantities.

Castelion has earned a head start. Whether that becomes a durable moat depends on what happens when production moves from dozens of units to hundreds and then thousands.

Q12Can Lockheed Martin, RTX or Anduril squeeze Castelion?

They can absolutely make Castelion’s life harder, especially now that low-cost mass production has become one of the hottest themes in defense.

Lockheed Martin and RTX have enormous advantages in installed programs, government relationships, manufacturing know-how and access to classified requirements. Their recent multiyear missile deals also give them the confidence to invest heavily in new production capacity. Lockheed is even developing lower-cost variants of existing systems.

Anduril creates a different threat. It is already building affordable missiles and autonomous weapons, has far more capital than Castelion, generated $2.2 billion of revenue last year and is now participating in the Pentagon’s low-cost containerized missile initiative.

The Pentagon itself appears to want this competition. Its latest procurement frameworks deliberately support several new entrants rather than handing the whole affordable-munitions market to one company.

Castelion’s current lead is valuable, but fragile. Blackbeard has a specific place in the Navy’s MACE plans, giving Castelion something concrete to defend. Over time, however, margins and future program wins will depend on whether it can keep lowering costs faster than better-funded rivals improve their own products.

Q13Is Castelion too dependent on Blackbeard and the U.S. government?

Yes. Castelion currently has major concentration risk, and a $13 billion valuation gives investors very little protection if Blackbeard hits a serious problem.

Publicly disclosed business is overwhelmingly tied to the U.S. military. Unlike Anduril, which now sells different products to several U.S. services and allied governments, Castelion’s visible commercial story still revolves heavily around one weapon family.

Management clearly knows this. The new financing is also being used for a much longer-range precision-strike system and lower-cost defensive weapons. Blackbeard technologies, components and manufacturing techniques are meant to carry over into those products.

Platform diversification is beginning too. Blackbeard is being developed for Navy aircraft, Army ground launch and potentially autonomous maritime platforms.

But those future products should not receive the same valuation weight as a program already entering procurement. If Blackbeard slips badly, fails certification or loses political support, Castelion currently has no second billion-dollar business ready to replace it.

Q14What has to go right for Castelion’s $13 billion valuation to work?

Castelion needs Blackbeard to turn into a genuine high-volume production program within the next few years, and then it needs to prove that its manufacturing model works for more than one missile.

The first condition looks increasingly possible. The Navy has already laid out a five-year MACE ramp that reaches more than 1,000 annual rounds, and the wider Pentagon framework creates room for still larger quantities after testing and validation.

The second condition is harder. Producing a few dozen missiles quickly is impressive. Producing 1,000 or more every year while keeping cost around a few hundred thousand dollars, meeting military reliability standards and earning acceptable margins is an industrial challenge on a completely different scale.

Castelion also needs its longer-range strike and defensive systems to become real procurement programs. One successful Blackbeard franchise could support a valuable company. Several weapons sharing the same low-cost manufacturing base could support something much larger.

If those pieces come together while U.S. munitions spending remains elevated, $13 billion could look reasonable surprisingly quickly. The valuation has simply pulled several years of expected success into the price today.

Q15What would make the $13 billion valuation look badly wrong?

A slower production ramp would hurt Castelion far more than a normal startup slowdown because the current price already assumes a rapid move into industrial-scale revenue.

The obvious problem would be Blackbeard getting stuck around a few hundred weapons a year. At those volumes, it becomes much harder to see how Castelion reaches the $500 million to $1 billion revenue range needed to support the valuation without relying on extraordinary multiples forever.

Technical delays could create the same problem. Certification, aircraft integration and operational testing are all still ahead. Missing the targeted 2027 fielding window by a year or two would push meaningful production revenue further away while competitors continue investing.

Cost is another risk worth watching closely. Today’s procurement documents support the idea of a roughly $400,000-class weapon. If the mature production cost drifts materially higher, part of Blackbeard’s appeal disappears because cheap volume is central to the entire proposition.

Finally, defense-tech valuations themselves could cool. Helsing at roughly 32 times projected revenue is already being described as expensive. Castelion currently sits far beyond that benchmark on the limited revenue information we have. If private markets decide that 20 or 30 times revenue is generous enough, Castelion will have to grow into $13 billion very quickly rather than relying on further multiple expansion.

Q16Is Castelion really worth $13 billion today?

We think Castelion’s $13 billion valuation is aggressive but defensible as a high-risk bet on production scale; the company has not yet generated enough visible revenue to say it has already earned that price.

The skeptical case is pretty clear. Revenue remains undisclosed, outside estimates are tiny relative to the valuation, Blackbeard still has certification and operational work ahead, and most of Castelion’s current value depends on one customer buying one weapon family at very large scale.

What keeps us from calling $13 billion irrational is how much stronger the evidence has become lately. The Navy has moved from funding development to ordering physical weapons. Its own budget now lays out a multi-year MACE production ramp reaching more than 1,000 rounds annually. Two separate procurement data points put Blackbeard in roughly the $400,000-class range. At the same time, the Pentagon is signing enormous multiyear missile contracts with incumbents and creating dedicated funding for cheaper new entrants.

The pieces line up unusually well. Castelion has built a cheap missile at the exact moment its biggest customer is trying to buy far more missiles.

The valuation therefore comes down to a very concrete threshold. If Castelion reaches high hundreds or thousands of Blackbeards per year, moves revenue toward $500 million to $1 billion, keeps unit costs low and turns the same manufacturing base into additional weapons, $13 billion can work. If production stays in the low hundreds or Blackbeard suffers a major delay, the valuation looks badly stretched.

So would we call Castelion worth $13 billion today? Barely, and only on a forward-looking basis. Current financials do not support it. Current procurement evidence makes the leap plausible.